Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease [Phase 2]

View source ↗

Summary

The Phase 2 trial of Abiprubart for Sjögren's syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Abiprubart

Snippet

Sponsor: Kiniksa Pharmaceuticals International, plc | Conditions: Sjögrens Disease | Phase 2 | Status: TERMINATED